Clara Technologies Slashes Executive Option Strikes After 98% Share Price Collapse

Clara Technologies awards executives options at 0.75 CAD, 82% below canceled grants, as shares crash 98% from quantum peak amid dilution and regulatory scrutiny.

The board of Clara Technologies has handed management a fresh batch of stock options at a fraction of the price granted just months earlier, in a move that underscores just how far the micro-cap has fallen since last summer’s quantum computing frenzy.

On May 4, the company awarded 1.75 million options to senior executives with an exercise price of 0.75 Canadian dollars (CAD) per share. The new awards vest in quarterly tranches over the next twelve months. That strike price sits roughly 82% below the 4.25 CAD level attached to 1.5 million options the board cancelled back in January — a tacit admission that the earlier grants had become hopelessly out of the money.

The restructuring of management incentives comes as Clara’s stock trades in penny territory. From a peak above 13 euros in July 2025, when retail speculation around quantum computing briefly sent the shares into the stratosphere, the equity has cratered by nearly 98%. The stock changed hands at 0.29 euros in the latest session, up about 8% on the day, though that bounce does little to mask the broader damage.

Shareholders have been hit by a double blow: the price collapse and relentless dilution. The number of outstanding shares has swelled by roughly 45% over the past twelve months to 27.23 million. Each new issuance has chipped away at existing holders’ stakes, a pattern that has drawn scrutiny from Canadian regulators. The Canadian Investment Regulatory Organization (CIRO) questioned the violent price swings as far back as the summer of 2025, and management at the time could offer no material explanation for the volatility.

Technically, the stock looks washed out. The relative strength index (RSI) has fallen to around 22, deep in oversold territory. But the fundamental picture offers little reason for optimism. Clara generated just 30,000 CAD in revenue in its latest fiscal year, against an operating loss of nearly 300,000 CAD. The company carries no debt and maintains a healthy current ratio of 6.52, which buys the board some breathing room, but the cash burn from operations remains a concern.

The new option grants could add to selling pressure once the first tranches become exercisable. Executives who lock in a 0.75 CAD strike price while the stock trades at the equivalent of roughly 0.29 euros have a powerful incentive to monetize their positions as soon as the shares show any sign of life.

Clara’s next annual report, covering fiscal 2026, is due in August. That filing will reveal whether the revamped compensation structure is aligning management’s interests with a genuine turnaround — or merely papering over the cracks in a business that has yet to prove it can generate meaningful revenue.